BNET Industries

Market Cap:$150.1B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Drug stocks climb; Athersys soars on Pfizer deal
-
Sanofi-Aventis to buy Gold Bond maker Chattem
-
Pfizer whistleblower wins 2009 honor for business ethics: Complaint led to largest criminal fine in...
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Adimab Signs Deal with Pfizer
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
News & Analysis
Filter by
pfizer inc. and procter & gamble co. - All News and Analysis
Holding Multinationals? Look Out for the Rising Dollar
Devin Hobbes submits: The dollar has rallied sharply since mid-July. Technical trader Adam Hewison, over at INO.com, has had a buy signal since June. As I'm writing, the US Dollar Index (DX-Y.NYB) has hit a new intra-day, 52 week high. It's back at levels not seen since September 2007.The Euro,...
Year to Date Performance of Dow 30 Members
Hickey and Walters Bespoke submit: Below we highlight the year to date performance of the 30 DJIA members with four months remaining in 2008. As shown, Wal-Mart WMT tops the list with a gain of 27.5% year to date. WMT is trailed by IBM (14%), McDonald's (8.2%), Johnson&Johnson...
Dividend Aristocrats Handily Outperforming Main Indexes in 2008
David I. Templeton submits: Three of the major U.S. domestic indexes (Dow Jones Industrial Average, S&P 500 Index & Nasdaq Composite Index) had a positive return for the month of August. However, the S&P's Dividend Aristocrats did outperform the three aforementioned benchmarks in August and YTD through August 29, 2008.Nasdaq...
Dow Price Targets from Last November
Hickey and Walters Bespoke submit: Barry Ritholtz over at the Big Picture recently highlighted Bloomberg's Chart of the Day showing that analyst profit forecasts are currently worse than ever. With that in mind, we pulled up a post we did back in November highlighting the average analyst price...
How Have 'Traditional Defensive Stocks' Done in This Downturn?
Larry Bellehumeur submits: Like many people on Seeking Alpha, I tend to watch a lot of Business-related programming on Bloomberg and BNN Canada. Over the past few months, more and more Analysts and Fund Managers are telling the viewers to “get more defensive” in their portfolio. When asked which...
Dow 30 Trading Ranges
Below we highlight the 30 Dow members with respect to their various trading ranges. After the recent volatility in the markets (S&P 500 +2.9% on Tuesday, -1.8% yesterday) some of these stocks are on the move. BAC had traded at its theoretical high of $34 and has declined over the...
$120 Oil's Struggle with the Dow Industrials
Steven Hansen submits: Is this round two of the price of oil on the Dow Industrials? Will the effects on the Dow of the 1973 Oil Crisis repeat itself? There are several similarities and differences. One similarity, which got me thinking, was that the percentage increase in oil prices was...
Board and Executive Compensation in S&P 500
Richard Shaw QVM Group submits: Executive compensation and board largess with high paid executives is a hot topic recently. That spurred us to look comprehensively at some factual comparative data on the total cost of boards of directors and top executive teams among the S&P 500 companies (proxy SPY...
Zacks Analyst Blog Highlights: Pfizer, Procter & Gamble and Dynavax Technologies
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer (NYSE: PFE), Procter & Gamble (NYSE: PG) and Dynavax Technologies...
Stock Guru Alerts - On The Go Inc (OTCBB: OGHC) Up Sharply Since Monday Open, Procter & Gamble Co (NYSE: PG) WSJ Today Mentions Gillette Takeover, Pfizer Inc (NYSE: PFE) Mentioned in WSJ, and Microsoft Corp (NasdaqNM: MSFT) in Talks to Buy Private Com
M2 PRESSWIRE-30 June 2005-StockGuruNews.com: Stock Guru Alerts - On The Go Inc (OTCBB: OGHC) Up Sharply Since Monday Open, Procter & Gamble Co (NYSE: PG) WSJ Today Mentions Gillette Takeover, Pfizer Inc (NYSE: PFE) Mentioned in WSJ, and Microsoft Corp (NasdaqNM: MSFT) in Talks to Buy...
- 1
- 2
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
